An extrudate to deliver a dual-active pharmaceutical ionic liquid

An extrudate to deliver a dual-active pharmaceutical ionic liquid

The purpose of this study is to develop a resorbable material from zein and to evaluate its ability to release [Lidocainium][Ibuprofenate] as an Active Principle - Liquid Ionic.

Biopolymers are gaining increasing attraction as an avenue for developing absorbable oral matrices for pharmaceuticals. Zein, the main storage protein in corn, has huge potential, particularly because it is hot-melt-processable and can interact with therapeutically-active compounds.
In parallel, dual active pharmaceutical ingredient-ionic liquids (API-IL) hold huge promise for future drugs, as they can be easily dosed and processed to prepare stable pharmaceuticals that can quickly cross through cell walls.
Including an  API-IL in a biopolymer matrix, such as plasticized zein, not only facilitates shaping into form but also helps ensure targeted delivery and controlled release.
The purpose of this study was to engineer a resorbable material from zein and address its ability to release Lidbu as a dual API-IL.

See also

> See the full result

Modification date : 11 September 2023 | Publication date : 19 July 2021 | Redactor : MW